Blog

Mar 14th:  FUJIFILM India, a leader in advanced diagnostic imaging and healthcare technology, has announced the installation of a comprehensive suite of advanced diagnostic and medical equipment at Porunai Hospitals, Tirunelveli, further strengthening the hospital’s diagnostic capabilities and reinforcing the role of technology in expanding access to quality healthcare in South India.

The installation includes CT System Supria 32, Amulet Innovality Mammography which includes the state-of-the-art features available globally, FDR Smart F – 40 kW Digital Radiography, Bone Mineral Densitometry (BMD), along with EP 6000 Endoscopy video processor with Multi-LED light source and Dry Chemistry analyser DRI-CHEM NX 600, enabling Porunai Hospitals to enhance its diagnostic ecosystem across multiple clinical domains.

At the center of this deployment is the Supria 32 CT system, a 32-slice CT platform designed to deliver high-resolution imaging with optimized radiation dose and efficient workflows across routine and advanced diagnostics. The installation marks the first deployment of the Supria 32 CT system in Tamil Nadu, reflecting Porunai Hospitals’ commitment to adopting advanced imaging technologies to support accurate diagnosis and improved patient outcomes. 

Complementing the CT platform is the FDR Smart F digital radiography system, which enables high-quality imaging with fast acquisition speeds and dose-optimized performance across a wide range of radiography applications. Designed to support high-throughput clinical environments, the system enhances operational efficiency while ensuring reliable diagnostic performance for everyday clinical needs.

The deployment also includes the Amulet Innovality mammography system, a digital mammography platform equipped with advanced detector technology and low-dose imaging capabilities. As the first installation of its kind in South Tamil Nadu, the system strengthens women’s healthcare services in the region by supporting early and accurate breast cancer detection through advanced imaging technology. 

Further strengthening preventive diagnostic capabilities, an advanced Bone Mineral Densitometry (BMD) system has also been installed, enabling precise assessment of bone health and early detection of osteoporosis. This installation marks the first advanced BMD system in South Tamil Nadu, expanding access to specialized diagnostics and preventive screening in the region. In addition to imaging technologies, the deployment also includes EP 6000 Endoscopy video processor with Multi-LED light source and Dry Chemistry analyser DRI-CHEM NX 600, helping Porunai Hospitals strengthen its diagnostic ecosystem across multiple clinical domains, including gastroenterology, pathology, and preventive screening.

Commenting on the development, Dr D.R. Sivakumar MBBS, MS, DLS, Medical Superintendent, Porunai Hospitals and Research Centre, said, “At Porunai Hospitals, our focus has always been to strengthen diagnostic capabilities so that patients in our region have access to reliable and advanced healthcare services. The installation of these advanced imaging and diagnostic systems significantly enhances our ability to provide accurate and timely diagnosis across multiple clinical areas, including radiology, preventive screening, etc.”

Speaking on the collaboration, Mr. Nagaraj Kempaiah, National Head – Private Business, FUJIFILM India, said: “At FUJIFILM India, our commitment is closely aligned with the Fujifilm Group’s global purpose of ‘Giving our world more smiles’ by expanding access to reliable, advanced, and patient-centric diagnostic technology. Tamil Nadu continues to be one of India’s most progressive healthcare markets, with a strong focus on preventive healthcare, cancer screening, and technology-driven clinical services. Partnerships such as this with Porunai Hospitals play an important role in bringing advanced imaging solutions closer to Tier-2 and Tier-3 regions. Our collaboration reflects Fujifilm’s commitment to strengthening regional healthcare infrastructure by supporting hospitals with innovative technologies that enable early detection, clinical confidence, and improved patient outcomes.”

Through collaborations with progressive healthcare institutions such as Porunai Hospitals, FUJIFILM India continues to expand access to advanced diagnostic technologies, supporting early detection, preventive healthcare, and improved clinical outcomes while enabling healthcare providers to manage increasing patient volumes with greater efficiency and diagnostic confidence.

DALLAS, Mar 14th:  Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn’t switch, according to a new study by UT Southwestern Medical Center researchers. The findings, published in JAMA Network Open, suggest that medication changes are not uncommon among patients undergoing weight loss and that clinicians should encourage them to change GLP-1RAs if necessary to promote continuity of care.

“This study provides one of the largest real-world descriptions to date of how adults with overweight or obesity use and switch GLP-1RAs over time,” said first author Luyu (Amber) Xie, Ph.D., Pharm.D., Assistant Professor in the Peter O’Donnell Jr. School of Public Health and co-Director of the Biostatistics and Data Science Core at UT Southwestern. “It highlights that long-term persistence is low and that switching between medications is a relatively common part of ongoing treatment rather than a sign of failure.”

The study examined insurance claims from nearly 127,000 U.S. adults with overweight or obesity who initiated GLP-1 therapy between 2019 and 2024. By tracking medication use over 12 months, the researchers found that treatment often did not follow a linear path. Instead, many patients adjusted therapy in response to side effects, access, insurance coverage, and the introduction of new medications.

GLP-1RAs, including semaglutide, liraglutide, and tirzepatide, are now a central part of obesity treatment. However, maintaining long-term adherence to the drugs has been challenging.  

In the study, only a quarter of the patients remained on any GLP-1RA one year after starting, with roughly 1 in 5 patients transitioning to a different GLP-1RA during that period. Patients who switched were more likely to continue treatment and showed higher adherence than those who remained on their initial medication, suggesting adjustments often reflected active management.
“Switching between GLP-1RA medications should be viewed as a normal part of long-term obesity care,” said senior author Sarah Messiah, Ph.D., M.P.H., Professor of Epidemiology and Pediatrics, Associate Dean for Research in the O’Donnell School of Public Health, and Director of the Child and Adolescent Population Health Program. “Persistence should not be judged by staying on a single drug indefinitely, but by maintaining engagement in care and working with clinicians to find sustainable, effective treatment strategies over time.”

The researchers also visualized treatment pathways to illustrate how patients transitioned among medications during the study period. Newer, once-weekly injectable therapies frequently served as both starting points and switch destinations, reflecting their growing role in obesity management.

“In today’s clinical environment, successful obesity care often involves adapting treatment over time rather than expecting a single medication to meet every patient’s needs indefinitely,” said co-author Jaime Almandoz, M.D., M.B.A., Professor of Internal Medicine in the Division of Endocrinology and Medical Director of UTSW’s Weight Wellness Program.

The findings underscore the importance of setting clear expectations with patients early in treatment, including the possibility that more than one medication may be prescribed before a long-term approach is identified. 

The authors said future research will explore how patient characteristics, specific medications, and timing of therapy influence treatment trajectories, with the goal of informing more personalized and sustainable approaches to obesity care.

Other UTSW researchers who contributed to this study are Diego Anazco Villarreal, M.D., Internal Medicine resident; Azucena Herrera Chancay, M.D., Internal Medicine fellow; M. Sunil Mathew, M.S., Senior Population Science Data Manager; and Jackson Francis, M.P.H., Population Science Project Coordinator.

The study was supported by the UTSW Clinical and Translational Science Award, the National Institutes of Health (1U54TR00236), the Texas Health Resource Clinical Scholar program, and the UTSW Nutrition & Obesity Research Center (NORC). 

Jaipur: In contemporary interiors, certain elements have the ability to define a space almost instantly. Among them, statement chandeliers hold a particularly influential role. More than sources of illumination, they act as architectural anchors, establishing visual identity, reinforcing spatial hierarchy, and bringing cohesion to the design. Their presence shapes not only how a room looks, but how it is experienced.

As homes increasingly embrace open layouts and expansive volumes, the role of the chandelier has become even more significant. These fixtures introduce structure within openness, helping organize space without the need for physical divisions. A well-placed chandelier naturally draws the eye, creating a focal point that grounds the surrounding design.

“A chandelier has the ability to transform the perception of a room,” says Naman Jain, Founder of Lumeil. “It becomes a visual reference point that helps define proportion, scale, and atmosphere. When chosen thoughtfully, it strengthens the architectural intent rather than simply adding decoration.”

In living areas, chandeliers often become the defining visual element. A piece like the Mushroom Medley Crystal Chandelier introduces depth through its layered crystal composition, allowing light to interact dynamically with the space. Its presence adds dimension without overwhelming the environment, making it particularly suited to contemporary interiors that balance minimalism with warmth.

Similarly, the Orbit Rose Gold Crystal Chandelier offers a sculptural expression of modern lighting. Its circular form introduces rhythm and continuity, while the rose gold finish brings a sense of subtle richness. Fixtures like these demonstrate how chandeliers contribute not only illumination, but also spatial character.

Their importance becomes even more evident in entrance foyers and double-height volumes, where lighting must complement architectural scale. A carefully selected chandelier enhances vertical continuity, guiding the eye upward and reinforcing the openness of the space.

“Entrance spaces set the tone for what follows,” explains Jain. “A chandelier placed here creates an immediate sense of identity. It introduces clarity and establishes the design language from the moment one enters.”

While chandeliers provide focal presence, wall lighting plays an equally important supporting role. Fixtures such as the Opalescent Warm White Indoor Wall Light introduce softness and depth, highlighting surfaces while ensuring visual continuity. These elements work together to create layered environments where light enhances both form and material.

Wall lights also contribute to the rhythm of a space, particularly in corridors and transitional areas. They ensure that the experience of moving through a space feels intentional rather than incidental.

At Lumeil, the approach to decorative lighting is rooted in understanding how fixtures interact with architecture. Each piece is selected not only for its visual appeal, but for its ability to integrate seamlessly into the design.

“We see lighting as an essential architectural element,” says Naman Jain. “The right chandelier becomes part of the space’s identity. It adds depth, reinforces structure, and ensures that the environment feels complete.”

As contemporary interiors continue to evolve toward openness and material clarity, statement chandeliers remain central to defining spatial character. They bring presence without excess and clarity without distraction. When thoughtfully integrated, they do more than illuminate. They help shape spaces that feel enduring, intentional, and complete.

Pic Credit: Pexel

In 2025, Gift Nifty—India’s key index for exchange-traded derivatives—achieved a record monthly turnover, reflecting its growing significance as a tool for market participants seeking early signals and better-informed trading strategies. The surge in activity underscores a broader shift in how investors, both domestic and foreign, approach pre-market analysis in India’s fast-moving equity markets.

Why Gift Nifty is Gaining Momentum

Gift Nifty provides a window into expected market movements before the regular trading session begins. By tracking overnight global trends, macroeconomic developments, and derivatives activity, traders can anticipate market direction, adjust positions, and manage risks more effectively.

Over the past few years, the index has increasingly attracted attention from foreign institutional investors (FII) and domestic institutional investors (DII). Investors now combine real-time FII and DII inflow and outflow data with Gift Nifty trends to make data-driven pre-market decisions, creating a feedback loop that strengthens market efficiency.

Record Turnover Signals Rising Engagement

The record monthly turnover in 2025 indicates that more participants are using Gift Nifty not just for speculative purposes but also for strategic hedging, arbitrage, and risk management. Analysts suggest that this trend reflects both the growing sophistication of Indian equity markets and the increased reliance on derivatives as a risk management tool.

Integrating FII and DII Data for Pre-Market Insights

Institutional flows play a crucial role in shaping market sentiment. By monitoring FII purchases or sales alongside DII activity, traders can identify likely market trends and potential reversals. For instance:

• FII buying trends often indicate bullish sentiment among global investors.

• DII flows can signal domestic confidence and provide a counterbalance to global pressures.

• Combined analysis enables pre-market positioning that aligns with anticipated market moves.

Market participants are increasingly integrating this data with Gift Nifty’s early signals, allowing for more precise risk-adjusted strategies ahead of the market open.

Implications for Traders and Investors

The rising importance of Gift Nifty suggests a few key takeaways for investors:

1. Enhanced Pre-Market Preparation – Traders can monitor overnight global cues and institutional flows to make informed decisions before the trading session begins.

2. Improved Risk Management – Combining derivative signals with institutional investor activity helps manage exposure and hedge portfolios more effectively.

3. Market Transparency and Efficiency – Higher turnover and data integration support better price discovery and reduce informational asymmetry.

Looking Ahead

As Indian markets continue to grow in depth and sophistication, Gift Nifty’s role as a pre-market barometer is likely to expand. The index not only provides a snapshot of market expectations but also reflects broader trends in investor behaviour, including reliance on data analytics, institutional flow tracking, and algorithmic trading tools.

For both retail and institutional participants, the combination of Gift Nifty signals and FII/DII flow data is increasingly becoming a cornerstone of pre-market strategy, highlighting how technology and real-time data are shaping the future of trading in India.